Wellgistics Health Inc. (Nasdaq: WGRX) announced on Aug. 13, 2025, “the launch of its Ripple Labs-powered XRP Implementation Program, giving independent pharmacies access to blockchain-based payments in the prescription drug space for the first time.” The program, one of the first large-scale healthcare deployments of XRP for prescription drug transactions, offers near-instant settlements, lower transaction costs, and direct transfers without intermediaries. CEO Brian Norton noted that independent pharmacy owners understand blockchain’s transformative potential as it scales across the industry.

The initiative, supported by RxERP—a serialized pharmaceutical ecommerce and enterprise resource planning platform—manages onboarding, transaction execution, and compliance oversight. Wellgistics Health stated:

Wellgistics Health is among the first healthcare companies to implement an XRP-based payment solution at scale.

The XRP ledger’s speed and scalability are tailored to the demands of the pharmaceutical supply chain, with the platform designed to help pharmacies improve liquidity, avoid banking delays, and track payments securely.

COO Tony Madsen highlighted that while the current phase focuses on streamlining payments to distributors, the long-term goal is a fully frictionless pharmacy payment ecosystem.

Regulatory safeguards have been a central focus, with the company affirming:

The XRP Payment Program has been developed to meet or exceed healthcare and financial regulatory standards, including HIPAA and anti-money laundering (AML) requirements.

“The system provides secure, traceable transactions while safeguarding sensitive data and maintaining privacy at every stage,” the company added. Future expansion includes onboarding pharmaceutical manufacturers and launching direct-to-patient programs, allowing home delivery of medications under physician oversight. Although some critics remain skeptical about blockchain’s longevity in healthcare, proponents point to cryptocurrency-based settlement systems as tools to cut costs, improve transparency, and strengthen operational efficiency across the sector.

免责声明：本文章仅代表作者个人观点，不代表本平台的立场和观点。本文章仅供信息分享，不构成对任何人的任何投资建议。用户与作者之间的任何争议，与本平台无关。如网页中刊载的文章或图片涉及侵权，请提供相关的权利证明和身份证明发送邮件到support@aicoin.com，本平台相关工作人员将会进行核查。